JMIR Cardio

Cardiovascular medicine with focus on electronic, mobile, and digital health approaches in cardiology and for cardiovascular health

Editor-in-Chief:

Gunther Eysenbach, MD, MPH, FACMI, Founding Publisher; Adjunct Professor, School of Health Information Science, University of Victoria, Canada


JMIR Cardio focuses on cardiovascular medicine with a special emphasis on health services research and electronic / digital health approaches in cardiology and for cardiovascular health, which includes ehealth and mhealth approaches for the prevention and treatment of cardiovascular conditions.

JMIR Cardio is indexed in Sherpa Romeo, DOAJ, PubMedPubMed Central, and Scopus. JMIR Cardio is an open access journal.

Recent Articles

Article Thumbnail
Mobile Apps for Cardiology

Numerous antineoplastic drugs such as chemotherapeutics have cardiotoxic side effects and can lead to long QT syndrome (LQTS). When diagnosed and treated in time, the potentially fatal outcomes of LQTS can be prevented. Therefore, regular electrocardiogram (ECG) assessments are critical to ensure patient safety. However, these assessments are associated with patient discomfort and require timely support of the attending oncologist by a cardiologist.

|
Article Thumbnail
Reviews on Cardiovascular Health and Medicine

The digital transformation of our health care system has experienced a clear shift in the last few years due to political, medical, and technical innovations and reorganization. In particular, the cardiovascular field has undergone a significant change, with new broad perspectives in terms of optimized treatment strategies for patients nowadays.

|
Article Thumbnail
Hypertension Prevention and Treatment

Digital health programs that incorporate frequent blood pressure (BP) self-monitoring and support for behavior change offer a scalable solution for hypertension management.

|
Article Thumbnail
Cardiac Risk and Cardiac Risk Calculators

In addition to aspirin, angiotensin-converting enzyme inhibitors, statins, and lifestyle modification interventions, novel pharmacological agents have been shown to reduce morbidity and mortality in atherosclerotic cardiovascular disease patients, including new antithrombotics, antihyperglycemics, and lipid-modulating therapies. Despite their benefits, the uptake of these guideline-directed therapies remains a challenge. There is a need to develop strategies to support knowledge translation for the uptake of secondary prevention therapies.

|
Article Thumbnail
Stroke

Stroke has multiple modifiable and nonmodifiable risk factors and represents a leading cause of death globally. Understanding the complex interplay of stroke risk factors is thus not only a scientific necessity but a critical step toward improving global health outcomes.

|
Article Thumbnail
Cardiovascular Disease Prevention

High blood pressure (BP) and physical inactivity are the major risk factors for cardiovascular diseases. Mobile health is expected to support patients’ self-management for improving cardiovascular health; the development of fully automated systems is necessary to minimize the workloads of health care providers.

|
Article Thumbnail
Coronary Heart Disease

Many current studies have claimed that the actual risk of heart disease among women is equal to that in men. Using a large machine learning algorithm (MLA) data set to predict mortality in women, data mining techniques have been used to identify significant aspects of variables that help in identifying the primary causes of mortality within this target category of the population.

|
Article Thumbnail
Telemonitoring in Cardiology

Electrocardiograms (ECGs) are used by physicians to record, monitor, and diagnose the electrical activity of the heart. Recent technological advances have allowed ECG devices to move out of the clinic and into the home environment. There is a great variety of mobile ECG devices with the capabilities to be used in home environments.

|
Article Thumbnail
Telemonitoring in Cardiology

Despite effective therapies, the economic burden of heart failure with reduced ejection fraction (HFrEF) is driven by frequent hospitalizations. Treatment optimization and admission avoidance rely on frequent symptom reviews and monitoring of vital signs. Remote monitoring (RM) aims to prevent admissions by facilitating early intervention, but the impact of noninvasive, smartphone-based RM of vital signs on secondary health care use and costs in the months after a new diagnosis of HFrEF is unknown.

|
Article Thumbnail
Cardiac Disease Management

The prediction of posttransplant health outcomes for pediatric heart transplantation is critical for risk stratification and high-quality posttransplant care.

|
Article Thumbnail
Cardiac Rehabilitation

The adherence to cardiac rehabilitation is low. Social media has been used to improve motivation and cardiac rehabilitation completion, but the authors did not find Facebook interventions for these purposes in the literature.

|
Article Thumbnail
Cardiac Disease Management

Introducing telemedicine in outpatient treatment may improve patient satisfaction and convenience. However, the optimal in-person visit interval for video-based telemedicine among patients with hypertension remains unreported in Japan.

|

Preprints Open for Peer-Review

There are no preprints available for open peer-review at this time. Please check back later.

We are working in partnership with